Cash flow The Scotts Miracle-Gro Company

Equities

SMG

US8101861065

Agricultural Chemicals

Market Closed - Nyse Other stock markets 01:30:02 06/06/2026 am IST			5-day change	1st Jan Change
57.67 ^USD	+1.48%		-2.25%	-1.17%

04/06	The Scotts Miracle-Gro Company Presents at 46th Annual William Blair Growth Stock Conference, Jun-03-2026 03:20 PM
02/06	UBS Adjusts Price Target on Scotts Miracle-Gro to $63 From $70, Maintains Neutral Rating	MT

3281b6186b64726b.rxb2oDNJWbtsnBvD_JZbNj9hY0osqgh7jVZnbDs478I.2nuyxl8sEIodqX-rj682eEcTOxVqnG4C1CUUJVIOu_SXXILsX3Fs-iDTTg

Published financial data: THE SCOTTS MIRACLE-GRO COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	492.5Cr	392.41Cr	355.13Cr	355.27Cr	341.31Cr
Total Revenues	492.5Cr	392.41Cr	355.13Cr	355.27Cr	341.31Cr
Cost of Goods Sold, Total	343.13Cr	289.1Cr	270.83Cr	261.87Cr	234.86Cr
Gross Profit	149.37Cr	103.31Cr	84Cr	93Cr	106.45Cr
Selling General & Admin Expenses, Total	67Cr	54Cr	49Cr	56Cr	60Cr
R&D Expenses	4.54Cr	4.53Cr	3.57Cr	-	-
Amortization of Goodwill and Intangible Assets - (IS)	2.91Cr	3.1Cr	2.26Cr	-	-
Other Operating Expenses	-	-4L	-1.47Cr	1.03Cr	1.84Cr
Other Operating Expenses, Total	74Cr	61Cr	54Cr	57Cr	62Cr
Operating Income	75Cr	42Cr	31Cr	36Cr	44Cr
Interest Expense, Total	-7.89Cr	-12Cr	-18Cr	-16Cr	-13Cr
Interest And Investment Income	41L	67L	64L	-	-
Net Interest Expenses	-7.48Cr	-11Cr	-17Cr	-16Cr	-13Cr
Income (Loss) On Equity Invest.	1.44Cr	-1.29Cr	-10Cr	-6.81Cr	-28L
Currency Exchange Gains (Loss)	18L	-13L	-1.47Cr	-96L	-3L
Other Non Operating Income (Expenses)	20L	2L	-61L	-55L	-53L
EBT, Excl. Unusual Items	69Cr	30Cr	1.28Cr	12Cr	31Cr
Restructuring Charges	3L	-18Cr	-20Cr	-6.86Cr	-4.71Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-52Cr	-1.03Cr	-25L	-
Gain (Loss) On Sale Of Investments	-	-	-10Cr	-6.46Cr	-70L
Gain (Loss) On Sale Of Assets	-	1.62Cr	-	-	-1.77Cr
Asset Writedown	-	-16Cr	-15Cr	-1.06Cr	-1.2Cr
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-1.68Cr	-	-	-	-
EBT, Incl. Unusual Items	68Cr	-56Cr	-45Cr	-2.36Cr	22Cr
Income Tax Expense	16Cr	-12Cr	-7.32Cr	1.13Cr	7.65Cr
Earnings From Continuing Operations	52Cr	-44Cr	-38Cr	-3.49Cr	15Cr
Earnings Of Discontinued Operations	-39L	-	-	-	-
Net Income to Company	51Cr	-44Cr	-38Cr	-3.49Cr	15Cr
Minority Interest	-9L	-	-	-	-
Net Income - (IS)	51Cr	-44Cr	-38Cr	-3.49Cr	15Cr
Net Income to Common Incl Extra Items	51Cr	-44Cr	-38Cr	-3.49Cr	15Cr
Net Income to Common Excl. Extra Items	52Cr	-44Cr	-38Cr	-3.49Cr	15Cr
Per Share Items
Net EPS - Basic	9.2	-7.88	-6.79	-0.61	2.52
Basic EPS - Continuing Operations	9.27	-7.88	-6.79	-0.61	2.52
Basic Weighted Average Shares Outstanding	5.57Cr	5.55Cr	5.6Cr	5.68Cr	5.76Cr
Net EPS - Diluted	8.96	-7.88	-6.79	-0.61	2.47
Diluted EPS - Continuing Operations	9.03	-7.88	-6.79	-0.61	2.47
Diluted Weighted Average Shares Outstanding	5.72Cr	5.55Cr	5.6Cr	5.68Cr	5.87Cr
Normalized Basic EPS	7.77	3.32	0.14	1.35	3.31
Normalized Diluted EPS	7.56	3.32	0.14	1.35	3.25
Dividend Per Share	2.52	2.64	2.64	2.64	2.64
Payout Ratio	27.9	-37.99	-39.23	-433.52	106.27
Supplemental Items
EBITDA	84Cr	53Cr	40Cr	45Cr	52Cr
EBITA	78Cr	46Cr	33Cr	38Cr	46Cr
EBIT	75Cr	42Cr	31Cr	36Cr	44Cr
EBITDAR	94Cr	67Cr	53Cr	57Cr	64Cr
Effective Tax Rate - (Ratio)	23.6	21.61	16.15	-47.88	34.51
Current Domestic Taxes	15Cr	3.21Cr	43L	49L	-29L
Current Foreign Taxes	27L	87L	16L	-53L	26L
Total Current Taxes	15Cr	4.08Cr	59L	-4L	-3L
Deferred Domestic Taxes	1.06Cr	-15Cr	-6.73Cr	78L	7.04Cr
Deferred Foreign Taxes	12L	-1.26Cr	-1.18Cr	39L	64L
Total Deferred Taxes	1.18Cr	-16Cr	-7.91Cr	1.17Cr	7.68Cr
Normalized Net Income	43Cr	18Cr	80L	7.67Cr	19Cr
Interest Capitalized	8L	22L	21L	11L	11L
Interest on Long-Term Debt	22L	34L	29L	19L	18L
Non-Cash Pension Expense	-14L	-2L	56L	57L	47L
Supplemental Operating Expense Items
Advertising Expense	17Cr	12Cr	12Cr	14Cr	15Cr
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	17Cr	12Cr	12Cr	14Cr	15Cr
Research And Development Expense From Footnotes	4.54Cr	4.53Cr	3.57Cr	3.46Cr	3.48Cr
Net Rental Expense, Total	9.97Cr	14Cr	13Cr	12Cr	12Cr
Imputed Operating Lease Interest Expense	2.95Cr	4.64Cr	5.95Cr	5.76Cr	5.02Cr
Imputed Operating Lease Depreciation	7.02Cr	9.53Cr	6.8Cr	6.46Cr	6.81Cr
Stock-Based Comp., SG&A Exp. (Total)	4.06Cr	3.43Cr	4.97Cr	5.72Cr	4.67Cr
Stock-Based Comp., Other (Total)	-	-	-	2.32Cr	2.23Cr
Total Stock-Based Compensation	4.06Cr	3.43Cr	4.97Cr	8.04Cr	6.9Cr

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	24Cr	8.68Cr	3.19Cr	7.16Cr	3.66Cr
Trading Asset Securities, Total	-	1.28Cr	1.67Cr	9L	5L
Total Cash And Short Term Investments	24Cr	9.96Cr	4.86Cr	7.25Cr	3.71Cr
Accounts Receivable, Total	48Cr	38Cr	30Cr	18Cr	19Cr
Other Receivables	-	-	-	-	-
Total Receivables	48Cr	38Cr	30Cr	18Cr	19Cr
Inventory	112.66Cr	134.35Cr	88Cr	59Cr	59Cr
Prepaid Expenses	15Cr	15Cr	16Cr	14Cr	12Cr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.86Cr	62L	88L	9L	-
Total Current Assets	202.4Cr	198.19Cr	139.78Cr	98Cr	94Cr
Gross Property Plant And Equipment	165.26Cr	167.28Cr	163.83Cr	168.03Cr	172.94Cr
Accumulated Depreciation	-74Cr	-78Cr	-77Cr	-81Cr	-84Cr
Net Property Plant And Equipment	92Cr	89Cr	87Cr	87Cr	89Cr
Long-term Investments	40Cr	31Cr	18Cr	9.1Cr	7.82Cr
Goodwill	61Cr	25Cr	24Cr	24Cr	24Cr
Other Intangibles, Total	71Cr	58Cr	44Cr	42Cr	40Cr
Loans Receivable Long-Term	3.58Cr	3.28Cr	-	-	-
Deferred Tax Assets Long-Term	-	14Cr	19Cr	19Cr	12Cr
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	11Cr	9.87Cr	9.49Cr	7.16Cr	6.88Cr
Total Assets	480Cr	429.68Cr	341.37Cr	287.19Cr	274.2Cr
Liabilities
Accounts Payable, Total	61Cr	42Cr	27Cr	25Cr	23Cr
Accrued Expenses, Total	25Cr	15Cr	23Cr	23Cr	25Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	5.76Cr	14Cr	5.04Cr	5Cr	5.52Cr
Current Portion of Leases	7.23Cr	8.26Cr	7.83Cr	7.79Cr	7.36Cr
Current Income Taxes Payable	3.17Cr	2.94Cr	2.85Cr	1.67Cr	1.66Cr
Other Current Liabilities	12Cr	14Cr	12Cr	12Cr	11Cr
Total Current Liabilities	114.04Cr	96Cr	77Cr	75Cr	74Cr
Long-Term Debt	221.17Cr	280.37Cr	254.24Cr	215.9Cr	203.67Cr
Long-Term Leases	26Cr	25Cr	24Cr	23Cr	21Cr
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	9.82Cr	8.21Cr	7.67Cr	7.3Cr	6.43Cr
Deferred Tax Liability Non Current	4.78Cr	85L	11L	70L	76L
Other Non Current Liabilities	2.67Cr	4.52Cr	5.2Cr	4.22Cr	3.65Cr
Total Liabilities	378.67Cr	414.91Cr	368.1Cr	326.25Cr	309.95Cr
Common Stock, Total	3L	3L	3L	3L	3L
Additional Paid In Capital	48Cr	36Cr	35Cr	36Cr	35Cr
Retained Earnings	160.51Cr	102.01Cr	49Cr	30Cr	29Cr
Treasury Stock	-100.24Cr	-109.18Cr	-100Cr	-95Cr	-89Cr
Comprehensive Income and Other	-6.64Cr	-14Cr	-11Cr	-11Cr	-11Cr
Total Common Equity	101.33Cr	15Cr	-27Cr	-39Cr	-36Cr
Minority Interest	-	-	-	-	-
Total Equity	101.33Cr	15Cr	-27Cr	-39Cr	-36Cr
Total Liabilities And Equity	480Cr	429.68Cr	341.37Cr	287.19Cr	274.2Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.52Cr	5.55Cr	5.66Cr	5.74Cr	5.8Cr
ECS Total Common Shares Outstanding	5.56Cr	5.55Cr	5.65Cr	5.71Cr	5.78Cr
Book Value / Share	18.22	2.66	-4.73	-6.84	-6.19
Tangible Book Value	-30Cr	-69Cr	-95Cr	-105.33Cr	-100.32Cr
Tangible Book Value Per Share	-5.42	-12.37	-16.78	-18.44	-17.37
Total Debt	260.35Cr	326.99Cr	290.62Cr	251.79Cr	238.02Cr
Net Debt	235.94Cr	317.03Cr	285.76Cr	244.54Cr	234.31Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-95L	-11L	14L	-13L	-27L
Debt Equivalent Oper. Leases	80Cr	113.36Cr	102Cr	98Cr	95Cr
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	21Cr	19Cr	9.19Cr	4.52Cr	5.36Cr
Account Code - Inventory Valuation	5	5	-	5	5
Inventories - Raw Materials, Total	24Cr	29Cr	27Cr	26Cr	22Cr
Inventories - Work In Process, Total	9.01Cr	12Cr	10Cr	8.41Cr	7.89Cr
Inventories - Finished Goods, Total	79Cr	93Cr	51Cr	25Cr	29Cr
Land - (BS)	14Cr	14Cr	15Cr	15Cr	16Cr
Buildings, Total	27Cr	26Cr	28Cr	31Cr	31Cr
Machinery, Total	66Cr	71Cr	71Cr	75Cr	77Cr
Full Time Employees	7.3T	6.1T	5.5T	5.3T	5.2T
Assets under Capital Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.68Cr	1.44Cr	1.51Cr	96L	1.2Cr

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	51Cr	-44Cr	-38Cr	-3.49Cr	15Cr
Depreciation & Amortization - CF	12Cr	14Cr	6.73Cr	6.49Cr	6.27Cr
Amortization of Goodwill and Intangible Assets - (CF)	3.09Cr	3.71Cr	2.52Cr	1.57Cr	1.23Cr
Depreciation & Amortization, Total	15Cr	18Cr	9.25Cr	8.06Cr	7.5Cr
Amortization of Deferred Charges, Total - (CF)	45L	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	1.77Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	67Cr	29Cr	8.43Cr	2.17Cr
(Income) Loss On Equity Investments - (CF)	-	1.29Cr	10Cr	6.81Cr	28L
Stock-Based Compensation (CF)	4.06Cr	3.43Cr	6.89Cr	8.04Cr	6.9Cr
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-5.23Cr	-26Cr	-5.74Cr	93L	7.08Cr
Change In Accounts Receivable	1.55Cr	10Cr	7.77Cr	13Cr	-1.66Cr
Change In Inventories	-50Cr	-20Cr	45Cr	29Cr	-1.79Cr
Change In Accounts Payable	20Cr	-17Cr	-15Cr	-16L	-3L
Change in Other Net Operating Assets	-11Cr	-5.68Cr	4.28Cr	-4.07Cr	39L
Cash from Operations	27Cr	-13Cr	53Cr	67Cr	37Cr
Capital Expenditure	-11Cr	-11Cr	-9.28Cr	-8.4Cr	-9.74Cr
Sale of Property, Plant, and Equipment	2L	6.33Cr	25L	24L	-
Cash Acquisitions	-13Cr	-24Cr	-	-	-
Divestitures	-	-	-	-	-25L
Investment in Marketable and Equity Securities, Total	-30Cr	-2.5Cr	-	-2.14Cr	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	3.7Cr	-	-85L
Other Investing Activities, Total	-87L	2.93Cr	-1.24Cr	26L	-37L
Cash from Investing	-54Cr	-28Cr	-6.57Cr	-10Cr	-11Cr
Long-Term Debt Issued, Total	214.32Cr	361.74Cr	133.62Cr	65Cr	70Cr
Total Debt Issued	214.32Cr	361.74Cr	133.62Cr	65Cr	70Cr
Long-Term Debt Repaid, Total	-136.15Cr	-293.73Cr	-168.98Cr	-103.95Cr	-82Cr
Total Debt Repaid	-136.15Cr	-293.73Cr	-168.98Cr	-103.95Cr	-82Cr
Issuance of Common Stock	1.52Cr	33L	23L	38L	1.19Cr
Repurchase of Common Stock	-13Cr	-26Cr	-93L	-51L	-1.84Cr
Common Dividends Paid	-14Cr	-17Cr	-15Cr	-15Cr	-15Cr
Common & Preferred Stock Dividends Paid	-14Cr	-17Cr	-15Cr	-15Cr	-15Cr
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-3.06Cr	-40L	-1.04Cr	1.57Cr	-1.11Cr
Cash from Financing	49Cr	26Cr	-52Cr	-53Cr	-29Cr
Foreign Exchange Rate Adjustments	6L	-4L	-1L	5L	-2L
Net Change in Cash	23Cr	-16Cr	-5.49Cr	3.97Cr	-3.5Cr
Supplemental Items
Cash Interest Paid	6.16Cr	11Cr	17Cr	16Cr	13Cr
Cash Income Tax Paid (Refund)	18Cr	2.72Cr	-1.82Cr	94L	1.29Cr
Levered Free Cash Flow	11Cr	-7.92Cr	56Cr	62Cr	24Cr
Unlevered Free Cash Flow	16Cr	-53.88L	68Cr	72Cr	32Cr
Change In Net Working Capital	40Cr	37Cr	-43Cr	-42Cr	68L
Net Debt Issued / Repaid	78Cr	68Cr	-35Cr	-39Cr	-12Cr

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.46	5.78	4.97	7.25	9.86
Return on Total Capital	15.57	7.47	6.32	9.56	13.33
Return On Equity %	60.28	-75.37	635.62	10.61	-38.82
Return on Common Equity	60.38	-75.37	635.62	10.61	-38.82
Margin Analysis
Gross Profit Margin %	30.33	26.33	23.74	26.29	31.19
SG&A Margin	13.58	13.68	13.88	15.73	17.68
EBITDA Margin %	17.05	13.4	11.23	12.53	15.17
EBITA Margin %	15.86	11.66	9.34	10.71	13.33
EBIT Margin %	15.23	10.72	8.63	10.27	12.97
Income From Continuing Operations Margin %	10.5	-11.15	-10.7	-0.98	4.25
Net Income Margin %	10.41	-11.15	-10.7	-0.98	4.25
Net Avail. For Common Margin %	10.49	-11.15	-10.7	-0.98	4.25
Normalized Net Income Margin	8.78	4.7	0.23	2.16	5.59
Levered Free Cash Flow Margin	2.31	-2.02	15.89	17.58	6.91
Unlevered Free Cash Flow Margin	3.31	-0.14	19.02	20.37	9.27
Asset Turnover
Asset Turnover	1.2	0.86	0.92	1.13	1.22
Fixed Assets Turnover	6.04	4.34	4.02	4.07	3.87
Receivables Turnover (Average Receivables)	10.05	9.1	10.4	14.77	18.77
Inventory Turnover (Average Inventory)	3.92	2.34	2.44	3.57	3.98
Short Term Liquidity
Current Ratio	1.77	2.06	1.81	1.31	1.27
Quick Ratio	0.64	0.5	0.46	0.33	0.3
Operating Cash Flow to Current Liabilities	0.24	-0.13	0.69	0.89	0.5
Days Sales Outstanding (Average Receivables)	36.33	40.1	35.1	24.78	19.45
Days Outstanding Inventory (Average Inventory)	93	155.93	149.85	102.57	91.72
Average Days Payable Outstanding	46.39	60.6	56.4	41.38	37.52
Cash Conversion Cycle (Average Days)	82.94	135.43	128.55	85.97	73.65
Long Term Solvency
Total Debt/Equity	256.93	2.21T	-1.09T	-644.62	-665.79
Total Debt / Total Capital	71.98	95.68	110.13	118.36	117.67
LT Debt/Equity	244.11	2.06T	-1.04T	-611.88	-629.76
Long-Term Debt / Total Capital	68.39	89.23	105.25	112.35	111.31
Total Liabilities / Total Assets	78.89	96.56	107.83	113.6	113.04
EBIT / Interest Expense	9.51	3.56	1.72	2.3	3.44
EBITDA / Interest Expense	11.9	5.65	2.96	3.57	4.94
(EBITDA - Capex) / Interest Expense	10.55	4.69	2.43	3.04	4.18
Total Debt / EBITDA	2.77	4.9	5.52	4.44	3.74
Net Debt / EBITDA	2.51	4.75	5.43	4.31	3.68
Total Debt / (EBITDA - Capex)	3.13	5.9	6.7	5.21	4.42
Net Debt / (EBITDA - Capex)	2.83	5.72	6.59	5.06	4.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.2	-20.32	-9.5	0.04	-3.93
Gross Profit, 1 Yr. Growth %	9.59	-30.84	-18.4	10.79	13.97
EBITDA, 1 Yr. Growth %	21.04	-37.71	-21.24	11.6	16.26
EBITA, 1 Yr. Growth %	22.93	-41.42	-24.36	14.68	19.61
EBIT, 1 Yr. Growth %	24.43	-43.95	-23.65	18.99	21.39
Earnings From Cont. Operations, 1 Yr. Growth %	33.7	-184.57	-13.12	-90.82	-516.05
Net Income, 1 Yr. Growth %	32.29	-185.37	-13.12	-90.82	-516.05
Normalized Net Income, 1 Yr. Growth %	28.04	-57.37	-95.66	851.16	148.98
Diluted EPS Before Extra, 1 Yr. Growth %	33.19	-187.3	-13.86	-90.95	-501.99
Accounts Receivable, 1 Yr. Growth %	-2.76	-21.64	-19.69	-41.88	5.71
Inventory, 1 Yr. Growth %	81.15	19.25	-34.48	-33.26	0.9
Net Property, Plant and Equip., 1 Yr. Growth %	27.82	-2.22	-2.46	0.23	1.49
Total Assets, 1 Yr. Growth %	41.99	-10.48	-20.55	-15.87	-4.52
Tangible Book Value, 1 Yr. Growth %	-42.69	127.69	38.08	11.12	-4.76
Common Equity, 1 Yr. Growth %	45.34	-85.42	-280.97	46.13	-8.47
Cash From Operations, 1 Yr. Growth %	-51.34	-147.51	-511.63	25.71	-44.37
Capital Expenditures, 1 Yr. Growth %	70.49	6.17	-18.24	-9.48	15.95
Levered Free Cash Flow, 1 Yr. Growth %	-81.85	-169.56	-438.91	7	-62.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-75.9	-103.3	-828.9	4.14	-56.26
Dividend Per Share, 1 Yr. Growth %	6.78	4.76	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.92	-2.54	-15.08	-4.85	-1.97
Gross Profit, 2 Yr. CAGR %	20.69	-12.94	-24.88	-4.92	12.37
EBITDA, 2 Yr. CAGR %	28.19	-13.19	-31.33	-7.86	16.07
EBITA, 2 Yr. CAGR %	30.61	-15.14	-34.92	-8.7	19.81
EBIT, 2 Yr. CAGR %	32.94	-16.49	-36.17	-6.74	23.17
Earnings From Cont. Operations, 2 Yr. CAGR %	8.84	6.34	-14.28	-71.76	-38.19
Net Income, 2 Yr. CAGR %	5.47	6.27	-13.88	-71.76	-38.19
Normalized Net Income, 2 Yr. CAGR %	43.63	-26.12	-86.4	-35.53	386.64
Diluted EPS Before Extra, 2 Yr. CAGR %	7.8	7.83	-13.29	-72.08	-39.69
Accounts Receivable, 2 Yr. CAGR %	25.2	-12.71	-20.67	-31.68	-21.62
Inventory, 2 Yr. CAGR %	44.4	46.98	-11.6	-33.87	-17.94
Net Property, Plant and Equip., 2 Yr. CAGR %	29.47	11.8	-2.34	-1.12	0.86
Total Assets, 2 Yr. CAGR %	25.89	12.74	-15.67	-18.25	-10.38
Tangible Book Value, 2 Yr. CAGR %	-24.4	14.23	77.31	23.87	2.88
Common Equity, 2 Yr. CAGR %	18.74	-53.97	-48.64	62.62	15.65
Cash From Operations, 2 Yr. CAGR %	9.41	-51.92	39.85	127.47	-16.38
Capital Expenditures, 2 Yr. CAGR %	58.78	34.54	-6.83	-13.97	2.45
Levered Free Cash Flow, 2 Yr. CAGR %	-3.66	-63.02	227.26	100.54	-35.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.42	-90.74	157.36	198.09	-32.06
Dividend Per Share, 2 Yr. CAGR %	6.3	5.77	2.35	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.74	7.53	-4.92	-10.32	-4.54
Gross Profit, 3 Yr. CAGR %	19.06	0.25	-14.8	-14.49	1
EBITDA, 3 Yr. CAGR %	24.92	0.96	-17	-19.25	-0.43
EBITA, 3 Yr. CAGR %	27.01	-0.02	-19.49	-21.38	-0.1
EBIT, 3 Yr. CAGR %	28.69	-0.32	-20.2	-21.43	1.83
Earnings From Cont. Operations, 3 Yr. CAGR %	59.45	0.06	-0.59	-59.29	-30.76
Net Income, 3 Yr. CAGR %	100.38	-1.71	-0.63	-59.16	-30.76
Normalized Net Income, 3 Yr. CAGR %	35.28	-4.19	-71.28	-43.82	1.15
Diluted EPS Before Extra, 3 Yr. CAGR %	59.39	0.48	0.05	-59.17	-32.08
Accounts Receivable, 3 Yr. CAGR %	15.9	7.09	-15.1	-28.49	-20.98
Inventory, 3 Yr. CAGR %	32.77	35.48	12.28	-19.51	-23.87
Net Property, Plant and Equip., 3 Yr. CAGR %	19.91	17.9	6.83	-1.49	-0.26
Total Assets, 3 Yr. CAGR %	16.26	12.36	0.33	-15.74	-13.91
Tangible Book Value, 3 Yr. CAGR %	-33.94	9.18	21.68	51.74	13.48
Common Equity, 3 Yr. CAGR %	41.91	-40.99	-27.35	-27.22	34.27
Cash From Operations, 3 Yr. CAGR %	-7.45	-17.15	-1.64	34.97	42.25
Capital Expenditures, 3 Yr. CAGR %	16.16	38.85	13.96	-7.72	-4.97
Levered Free Cash Flow, 3 Yr. CAGR %	-18.37	-13.57	-0.86	127.99	14.98
Unlevered Free Cash Flow, 3 Yr. CAGR %	-14.74	-69.31	2.42	92.15	57.22
Dividend Per Share, 3 Yr. CAGR %	5.6	5.79	3.81	1.56	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.47	8.23	5.92	2.4	-3.75
Gross Profit, 5 Yr. CAGR %	10.51	1.21	-0.97	-1.85	-4.82
EBITDA, 5 Yr. CAGR %	12.58	1.01	-1.52	-2.71	-5.79
EBITA, 5 Yr. CAGR %	13.4	0.34	-2.75	-3.64	-6.46
EBIT, 5 Yr. CAGR %	13.54	-0.25	-2.74	-2.99	-5.99
Earnings From Cont. Operations, 5 Yr. CAGR %	16.02	17.15	24.4	-39.67	-17.8
Net Income, 5 Yr. CAGR %	10.2	14.92	42.94	-40.31	-17.82
Normalized Net Income, 5 Yr. CAGR %	14.82	-2.16	-46.03	-18.22	-10.79
Diluted EPS Before Extra, 5 Yr. CAGR %	17.8	19.1	24.94	-39.8	-18.29
Accounts Receivable, 5 Yr. CAGR %	9.89	5.74	-0.41	-10.53	-17.77
Inventory, 5 Yr. CAGR %	23.34	26.95	12.83	1.69	-0.95
Net Property, Plant and Equip., 5 Yr. CAGR %	15.52	13.86	10.46	9.89	4.4
Total Assets, 5 Yr. CAGR %	11.74	9.36	2.25	-1.06	-4.1
Tangible Book Value, 5 Yr. CAGR %	-2.76	4.85	-1.94	14.83	13.78
Common Equity, 5 Yr. CAGR %	7.22	-25.62	-5.5	-11.48	-12.5
Cash From Operations, 5 Yr. CAGR %	2.16	-18.7	9.17	24.1	-7.82
Capital Expenditures, 5 Yr. CAGR %	12.89	10.28	6.35	14.65	9.21
Levered Free Cash Flow, 5 Yr. CAGR %	-18.93	-26.94	21.94	38.46	-16.43
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.84	-58.32	20.74	31.18	-12.83
Dividend Per Share, 5 Yr. CAGR %	5.7	5.4	4.29	3.43	2.27